Tyler Bussian
Stock Analyst at Brookline Capital
(0.12)
# 4,371
Out of 5,006 analysts
5
Total ratings
25%
Success rate
-30.45%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tyler Bussian
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COCH Envoy Medical | Initiates: Buy | $9 | $0.81 | +1,005.65% | 1 | Oct 14, 2024 | |
| CRVO CervoMed | Initiates: Buy | $63 | $8.70 | +624.14% | 1 | Jul 8, 2024 | |
| IMUX Immunic | Initiates: Buy | $10 | $0.98 | +922.18% | 1 | Apr 5, 2024 | |
| ANVS Annovis Bio | Downgrades: Hold | $9 | $2.22 | +305.41% | 2 | Feb 28, 2024 |
Envoy Medical
Oct 14, 2024
Initiates: Buy
Price Target: $9
Current: $0.81
Upside: +1,005.65%
CervoMed
Jul 8, 2024
Initiates: Buy
Price Target: $63
Current: $8.70
Upside: +624.14%
Immunic
Apr 5, 2024
Initiates: Buy
Price Target: $10
Current: $0.98
Upside: +922.18%
Annovis Bio
Feb 28, 2024
Downgrades: Hold
Price Target: $9
Current: $2.22
Upside: +305.41%